Servicio de Cardiooncologia en un Hospital Terciario: Experiencia del Hospital Hermanos Ameijeiras

Juan Adolfo Prohias Martínez, Daysi Luperon Loforte, Alain Gutierrez Lopez, Ramón Claro Valdés

Texto completo:

PDF

Resumen

La mortalidad de los pacientes oncológicos se ha reducido significativamente debido a los avances en el diagnóstico precoz y el tratamiento del cáncer. No obstante, para mejorar el pronóstico se deben prevenir, diagnosticar y tratar las complicaciones derivadas de los tratamientos oncológicos mediante la constitución de equipos multidisciplinarios entre oncólogos y cardiólogos. Se presenta la experiencia de la cardioncologia en el Hospital Hnos. Ameijeiras como modelo de organización en un hospital terciario potencialmente aplicable a hospitales secundarios en el país con sus resultados en el diagnóstico y tratamiento de la cardiotoxicidad y en el seguimiento de los sobrevivientes de cáncer.

Palabras clave

cardiología, oncología, cardiooncología, cáncer, cardiotoxicidad

Referencias

Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977–1010.

Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet. 2014;383:549–557.

Freeman AM, Herrmann J, Iliescu C, et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015; 65:2739–2746.

Fiuza M, Ribeiro L, Magalhães A, et al. Organization and implementation of a cardio-oncology program. Rev Port Cardiol. 2016; 35(9):485-94.

Barros-Gomes S, Herrmann J, Mulvagh SL, Lerman A, Lin G, Villarraga HR. Rationalefor setting up a cardio-oncology unit: our experience at Mayo Clinic. Cardio-Oncology. 2016; 2:1–9.

Mehta LS,Watson K E, Barac A et al: Cardiovascular disease and breast cancer Where these entities Intersect. Circulation. 2018; 137: e1-e35.

Gujral DM, Manisty C, Lloyd G, et al. Organisation & models of cardio oncology clinics. Int J Cardiol 2016; 214:381–2.

Sulpher J, Mathur S, Graham N, et al. Clinical experience of patients referred to a multidisciplinary Cardiac Oncology Clinic: an observational study. J Oncol. 2015; 671232.

Okwuosa T, Barac A. Burgeoning cardio-oncology programs: challenges and opportunities for early career cardiologists/faculty directors. J Am Coll Cardiol. 2015; 66:1193.

Snipelisky D,Yoon Park J, Lerman A et al. How to develop a cardioncology clinic. Heart Failure Clin. 2017; (13) 347-359.

Lopez Fernandez T, Martin Garcia A, Santaballa Beltran A et al. Cardio-Onco-Hematologia en la práctica clínica. Rev Esp Cardiol 2017; 70(6)474-486.

Pavo N, Raderer M, Hülsmann M, et al. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Heart. 2015;101:1874–1880.

Wang L, Tan TC, Halpern EF, et al. Major cardiac events and the value of echocardiographic evaluation in patients receiving anthracycline-based chemotherapy. Am J Cardiol. 2015;116:442–446.

Parent S, Pituskin E, Paterson DI. The cardio-oncology program: a multidisciplinary approach to the care of cancer patients with cardiovascular disease. Can J Cardiol. 2016; 32:847–851.

Lenihan DJ, Hartlage G, DeCara J, et al. Cardio-oncology training: A proposal from the international cardioncology society and canadian cardiac oncology network for a new multidisciplinary specialty. J Card Fail. 2016; 22:465–471.

Al-Kindi SG, Oliveira GH. Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology. Mayo Clin Proc. 2016;91:81–83.

Barac A, Murtagh G, Carver JR, et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015; 65: 2739–46.

Herrmann J, Yang EH, Iliescu CA, et al. Vascular toxicities of cancer therapies: The old and the new – an evolving avenue. Circulation. 2016; 133:1272–1289.

Lenneman CG, Sawyer DB. Cardio-oncology: an update on cardiotoxicity of cancer-related treatment. Circ Res. 2016; 118:1008–1020.

Enlaces refback

  • No hay ningún enlace refback.




Copyright (c) 2020 Juan Adolfo Prohias Martínez, Daysi Luperon Loforte, Alain Gutierrez Lopez, Ramón Claro Valdés

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.